Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis

Xu, C. and Lau, C. L. and Clark, J. and Rafferty, A. C. and Mills, D. J. and Ramsey, L. and Gilbert, B. and Doi, S. A. R. and Furuya-Kanamori, L.

Vaccine (2021) 39: 1044–1050

DOI: 10.1016/j.vaccine.2021.01.023

Abstract

BACKGROUND: There are a myriad of vaccine schedules for rabies pre- (PrEP) and post-exposure prophylaxis (PEP) that differ in the number and timedoses, number of visits, length of schedule, and route of administration. The objective of this study was to systematically review the evidence and investigate how thedifferences in schedules influence titres over time. METHODS: Four databaseswere searched from inception to January 2020 for rabies PrEP and PEP studies. Adose-response meta-analysis was utilised to pool geometric mean titres (GMT) over time. Subgroup analyses by route of administration, age group, and schedule were conducted. RESULTS: 80 studies met the inclusion criteria and contributed with 191 datasets and 12,413 participants. Both intradermal (ID) and intramuscular (IM) PrEP/PEP produce adequate GMTs. Significantly lower GMT levels were achieved in older (\textgreater50yrs) compared to younger (\textless50yrs) participants. Short 1-week schedules were as effective as longer schedules that can take between 3 and 12 weeks to complete. CONCLUSIONS: Several effective ID and IM schedules were identified, the selection of a schedule should take into account the patient’s needs, costs, availability to return for subsequent doses, and the time required to complete the schedule. Older individuals warrant special attention as they develop lower antibody response.

Citation

Xu, C., Lau, C. L., Clark, J., Rafferty, A. C., Mills, D. J., Ramsey, L., Gilbert, B., Doi, S. A. R., & Furuya-Kanamori, L. (2021). Immunogenicity after pre- and post-exposure rabies vaccination: A systematic review and dose-response meta-analysis. Vaccine, 39(7), 1044–1050. https://doi.org/10.1016/j.vaccine.2021.01.023 Aged, Humans, Vaccination, Injections, Intramuscular, *Antibodies, competing financial interests or personal relationships that could have appeared to, influence the work reported in this paper., *Intradermal, *Intramuscular, *Rabies Vaccines, *Rabies/prevention & control, *Seroconversion, *Seropositive, *Titre, *Vaccine, Antibodies, Viral, Injections, Intradermal, Post-Exposure Prophylaxis

Keywords

• Aged
• Humans
• Vaccination
• Injections
• Intramuscular
• *Antibodies
• competing financial interests or personal relationships that could have appeared to
• influence the work reported in this paper.
• *Intradermal
• *Intramuscular
• *Rabies Vaccines
• *Rabies/prevention & control
• *Seroconversion
• *Seropositive
• *Titre
• *Vaccine
• Antibodies
• Viral
• Injections
• Intradermal
• Post-Exposure Prophylaxis